NFSG
CRBP icon

Newbridge Financial Services Group’s Corbus Pharmaceuticals CRBP Stock Holding History

Newbridge Financial Services Group’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$150 Hold
16
– – ﹤0.01% 1191
2026
Q1 		$150 Buy
+16
New +$135 ﹤0.01% 1142
2021
Q4 		– Sell
-367
Closed -$11K – 1432
2021
Q3 		$11K Buy
+367
New +$14.5K 0.01% 841

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Newbridge Financial Services Group's CRBP Position: Q2 2026 in Review

Newbridge Financial Services Group held its Corbus Pharmaceuticals (CRBP) position steady in Q2 2026 at 16 shares worth $150. The position accounts for ﹤0.01% of the portfolio, ranked #1191.

Newbridge Financial Services Group first reported a position in CRBP in Q3 2021 and has held it in 3 quarters since. The position peaked at $11K in Q3 2021. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Newbridge Financial Services Group held 16 shares of Corbus Pharmaceuticals worth $150 as of Q2 2026.
  • Newbridge Financial Services Group left its Corbus Pharmaceuticals share count unchanged in Q2 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #1191 holding.
  • Newbridge Financial Services Group first reported a position in Corbus Pharmaceuticals in Q3 2021 and has held it in 3 quarters since.
  • Newbridge Financial Services Group's Corbus Pharmaceuticals position peaked at $11K in Q3 2021.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.